Skip to main content

Table 4 Most cited neuroblastoma papers

From: A scientometric analysis of neuroblastoma research

Authorsa Article Journal Year Vol Issue Page TC TC per year
Broder GM, Pritchard J, Berthold F, Hedborg F Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993 11 8 1466–77 1450 55.7
Kaghad M,Bonnet H, Yang A, Caput D Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 1997 90 4 809–19 1403 63.7
Broder GM Neuroblastoma: Biological insights into a clinical enigma Nat Rec Cancer 2003 3 3 203–16 1328 83.0
Matthay KK, Villablanca JG, Seeger RC, Reynolds Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid N Engl J Med 1999 341 16 1165–73 1246 62.3
Maris JM, Hogarty MD, Bagatell R, Cohn SL Neuroblastoma Lancet 2010 369 9579 2106–20 1153 96.1
Maris JM Recent Advances in Neuroblastoma N Engl J Med 2010 362 23 2202–11 792 88.0
Yu AL, Gilman AL, Ozkaynak MF, Sondel PM Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma N Engl J Med 2010 363 14 1324–34 707 78.5
Mosse YP, Laudenslager M, Longo L, Maris JM Identification of ALK as a major familial neuroblastoma predisposition gene Nature 2008 455 7215 930–5 704 64.0
Shimada H, Chatten J, Newton WA, Misugi K Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas J Natl Cancer Inst 1984 73 2 405–16 686 19.6
Pule M, Savoldo B, Myers GD, Brenner MK Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma Nat Med 2008 14 11 1264–70 674 61.3
  1. a first, second, third, and last authors